Impact of von Willebrand disease on health-related quality of life in a pediatric population

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 3, 2011, Pages 502-509

  De Wee, E M ^a   Fijnvandraat, K ^b   De Goede Bolder, A ^a,g   Mauser Bunschoten, E P ^c   Eikenboom, J C J ^d   Brons, P P ^e   Smiers, F J ^d   Tamminga, R ^f   Oostenbrink, R ^a   Raat, H ^a   Van Der Bom, J G ^d   Leebeek, F W G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

^g SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Bleeding; Health related quality of life; Pediatrics; Von Willebrand disease

Indexed keywords

ADOLESCENT; ARTICLE; ATTITUDE TO HEALTH; BLEEDING; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMOTION; FAMILY FUNCTIONING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PHENOTYPE; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; STRUCTURED QUESTIONNAIRE; VON WILLEBRAND DISEASE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMOTIONS; FEMALE; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PHENOTYPE; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOLOGY; VON WILLEBRAND DISEASES;

EID: 79952058550     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04175.x     Document Type: Article

References (42)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001; 14: 257-79.
3. Kessler CM. Diagnosis and treatment of von Willebrand disease: new perspectives and nuances. Haemophilia 2007; 13(Suppl. 5): 3-14.
4. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
5. Kouides PA. Current understanding of von Willebrand's disease in women - some answers, more questions. Haemophilia 2006; 12(Suppl. 3): 143-51.
6. Kadir RA, Chi C. Women and von Willebrand disease: controversies in diagnosis and management. Semin Thromb Hemost 2006; 32: 605-15.
7. Nosek-Cenkowska B, Cheang MS, Pizzi NJ, Israels ED, Gerrard JM. Bleeding/bruising symptomatology in children with and without bleeding disorders. Thromb Haemost 1991; 65: 237-41.
8. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004; 351: 683-94.
9. de Wee EM, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom JC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom B, Meijer K, Raat H, Leebeek FW. Health related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost 2010; 8: 1492-9.
10. Colletti CJ, Wolfe-Christensen C, Carpentier MY, Page MC, McNall-Knapp RY, Meyer WH, Chaney JM, Mullins LL. The relationship of parental overprotection, perceived vulnerability, and parenting stress to behavioral, emotional, and social adjustment in children with cancer. Pediatr Blood Cancer 2008; 51: 269-74.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9.
12. Raat H, Landgraf JM, Oostenbrink R, Moll HA, Essink-Bot ML. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res 2007; 16: 445-60.
13. Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002; 55: 67-76.
14. Raat H, Mohangoo AD, Grootenhuis MA. Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol 2006; 6: 180-5.
15. Raat H, Landgraf JM, Bonsel GJ, Gemke RJ, Essink-Bot ML. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res 2002; 11: 575-81.
16. Landgraf JM, Abetz L, Ware JE Jr. Child Health Questionnaire. A User's Manual. Boston: The Health Institute, New England Medical Center, 1996.
17. Landgraf JM. The Infant/Toddler Child Health Questionnaire: Conceptual framework, Logic Content, and Preliminary Psychometric Results. Boston, MA: Health Act, 1994.
18. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418-21.
19. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
20. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Acedemic Press, 1977.
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-92.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
23. Barr RD, Sek J, Horsman J, Furlong W, Saleh M, Pai M, Walker I. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol 2003; 73: 108-14.
24. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
25. Oostenbrink R, Jansingh-Piepers EM, Raat H, Nuijsink M, Landgraf JM, Essink-Bot ML, Moll HA. Health-related quality of life of pre-school children with wheezing illness. Pediatr Pulmonol 2006; 41: 993-1000.
26. Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, Smit C, Zwart-van Rijkom JE, Willemse J, Rosendaal FR. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood 2004; 104: 3494-500.
27. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
28. Plug I, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR, van der Bom JG. Social participation of patients with hemophilia in the Netherlands. Blood 2008; 111: 1811-15.
29. Berntorp E, Abshire T. The von Willebrand disease prophylaxis network: exploring a treatment concept. J Thromb Haemost 2006; 4: 2511-12.
30. von Mackensen S. Assessment of health-related quality of life in VWD patients - results of the VWD-QoL pilot-study. Haemophilia Meeting Abstracts 2010; 16: 139.
31. Moorthi C, Bade A, von Mackensen S, Overberg D, Auerwald G. Clinical situation in patients with von Willebrand disease in combination with a newly developed disease-specific quality of life questionnaire (Wilqol) for Germany. Haemophilia Meeting Abstracts 2010; 16: 151.
32. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull 1987; 101: 213-32.
33. Chang PC, Yeh CH. Agreement between child self-report and parent proxy-report to evaluate quality of life in children with cancer. Psychooncology 2005; 14: 125-34.
34. Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children's health-related quality of life: an analysis of 13, 878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 2007; 5: 2.
35. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review Qual Life Res 2001; 10: 347-57.
36. Baca CB, Vickrey BG, Hays RD, Vassar SD, Berg AT. Differences in child versus parent reports of the child's health-related quality of life in children with epilepsy and healthy siblings. Value Health 2010; 13: 778-86.
37. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
38. Gill JC, Christopherson PA, Flood VH, Friedman KD, Montgomery RR. The Zimmerman Program Investigators. Bleeding Scores in von Willebrand Disease (VWD) Re-Visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD. ASH Annual Meeting Abstracts. 16 November 2008; 112 (11): 425.
39. Federici AB, Mannucci PM, Castaman G, Baronciani L, Bucciarelli P, Canciani MT, Pecci A, Lenting PJ, De Groot PG. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 2009; 113: 526-34.
40. Bowman M, Hopman WM, Rapson D, Lillicrap D, Silva M, James P. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population. Pediatr Blood Cancer 2010; 55: 171-3.
41. Biss TT, Blanchette VS, Clark DS, Bowman M, Wakefield CD, Silva M, Lillicrap D, James PD, Rand ML. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010; 8: 950-6.
42. Boren MT, Ramey J. Thinking aloud: reconciling theory and practice. IEEE Trans Professional Commun 2000; 43: 261-78.